While anti-TNF-α drugs in the progression of kidney disease may favor deterioration of renal function, and their efficacy and safety have been demonstrated in cases of arthritis, however, it may contribute to an increased risk of lymphoma and skin cancer [64]. This evidence concerns the gene TNF and skin neoplasm.